About the Journal

Journal Title: Journal of Hematology and Transfusion Medicine

ISSN 2985-2390 (Print)

ISSN 2985-2404 (Online) (Since October 2023)

Journal Abbreviation: J Hematol Transfus Med

Established in 1991, the journal was originally published as the Thai Journal of Hematology and Transfusion Medicine (pISSN: 0858-2505). In 2008, it adopted its current title, Journal of Hematology and Transfusion Medicine (pISSN: 2985-2390), reflecting its continued commitment to publishing high-quality research in hematology and transfusion medicine. Since its establishment in 1999, the Journal has maintained an uninterrupted publication record, publishing more than 140 issues and over 1,200 articles over three decades.

The journal has been certified as a Tier 1 journal by the Thai-Journal Citation Index (TCI) Centre, recognizing its high editorial quality and publication standards. To further enhance its quality, accessibility, and international impact, the journal has accepted only English-language manuscript submissions and has offered full online access (eISSN: 2985-2404) since Issue 4 of 2023

Aims and Scope

Journal of Hematology and Transfusion Medicine is a quarterly peer-reviewed journal that encourages ongoing international research and exchange of scientific literature among peers through publication of research, review, case report, short communication and editorial. The articles related to the most recent advancement in the field would be very supportive for the researchers, scholars and academicians in hematology and transfusion medicine.  All the articles published online are made publicly available in the PDF files for free-of-charge.

The Journal welcomes submissions on a broad range of topics in hematology and transfusion medicine, including, but not limited to, the following areas: basic biomedical sciences, translational research, clinical research, clinical case reports, nursing, pharmacology, preventive medicine, health policy, and other health-related issues relevant to hematology and transfusion medicine.

Journal of Hematology and Transfusion Medicine is an official Journal of the Thai Society of Hematology and the National Blood Centre, Thai Red Cross Society. However, contributions written in English are welcomed from around the world, submit your manuscript using our online submission system or on the website at https://www.tci-thaijo.org/index.php/JHematolTransfusMed. If you require any further information or help, please contact the editorial office at sommaphun.t@tsh.or.th or nbcjournal@gmail.com.

Type of paper: Original article, Case report, Review article, Special article

Language: Full text in English, abstract both in Thai and English

Free Access: Online 

Publication Frequency

Quarterly, 4 issues a year

  • Issue 1 January-March
  • Issue 2 April-June
  • Issue 3 July-September
  • Issue 4 October-December

Abstracting and indexing

The Journal of Hematology and Transfusion Medicine is indexed in the following databases:

  • Thailand Citation Index (TCI): Indexed in the Tier 1 database of the Thailand Citation Index (TCI) Centre.
  • Google Scholar

Article Processing Charges 

The Journal of Hematology and Transfusion Medicine does not charge any submission fees or article processing charges (APCs). There are no fees at any stage of the publication process.

All articles published in the journal are fully open access and are freely and permanently available to readers worldwide through the journal website, without subscription fees or registration requirements.

Publication Malpractice Statement

The Journal of Hematology and Transfusion Medicine is committed to maintaining the highest standards of research integrity and publication ethics. The journal aims to prevent all forms of scientific misconduct, including fabrication, falsification, plagiarism, duplicate or redundant publication, inappropriate authorship, and other unethical publishing practices.

All submitted manuscripts are screened for plagiarism before entering the peer-review process. Allegations of scientific misconduct are investigated thoroughly and handled in accordance with internationally recognized ethical standards and best practices. In addressing suspected misconduct, the Journal of Hematology and Transfusion Medicine follows the principles, guidelines, and flowcharts developed by the Committee on Publication Ethics (COPE) (available at: http://publicationethics.org/resources), as well as the recommendations of the Council for International Organizations of Medical Sciences (CIOMS), the World Association of Medical Editors (WAME) (http://www.wame.org/about/recommendations-on-publicationethics-policie), and the Council of Science Editors (CSE) (http://www.councilscienceeditors.org/resource-library/editorialpolicies/).

The journal also adheres to the Principles of Transparency and Best Practice in Scholarly Publishing, a joint statement issued by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the World Association of Medical Editors (WAME), and the Open Access Scholarly Publishers Association (OASPA)(https://doaj.org/bestpractice).

Subscription

The annual subscription rate for the print edition is USD 8 per year. A lifetime subscription is also available for a one-time fee of USD 80.

Open Access Policy

The Journal of Hematology and Transfusion Medicine provides immediate, free, and unrestricted open access to all published content, based on the principle that making research freely available to the public promotes the global exchange of knowledge and advances scientific discovery and clinical practice.

Ownership and Management

The Journal of Hematology and Transfusion Medicine is the official journal of the Thai Society of Hematology and the National Blood Centre, Thai Red Cross Society. The journal is fully supported by both organizations through financial, administrative, and operational resources. They also oversee and support the journal's development to ensure the highest standards of editorial quality, a rigorous and independent peer-review process, and the continued provision of open-access publishing for researchers, clinicians, scientists, and academics worldwide.

Publisher

The Journal of Hematology and Transfusion Medicine is published jointly by the Thai Society of Hematology and the National Blood Centre, Thai Red Cross Society, Bangkok, Thailand.

Journal of Hematology and Transfusion Medicine is published by the Thai Society of Hematology and National Blood Centre, Thai Red Cross Society, Bangkok, Thailand.  

Copyright and Licensing

All manuscripts accepted for publication must have their copyright transferred to the Journal of Hematology and Transfusion Medicine. No part of any published article may be reproduced, stored, or transmitted in any form or by any means without prior written permission from the Journal of Hematology and Transfusion Medicine. The authors are solely responsible for the content of their articles, except for errors introduced during the publication process. All articles published in the Journal of Hematology and Transfusion Medicine are distributed under the Creative Commons (CC) BY-NC-ND 4.0 license found at (https://creativecommons.org/licenses/by-nc-nd/4.0/). This license permits others to copy and redistribute the material in any medium or format for non-commercial purposes, provided that the work is not modified or adapted and appropriate credit is given to the original authors and the journal. No additional permission is required for such distribution when these license terms are met.

Revenue Sources

The Journal of Hematology and Transfusion Medicine does not charge submission fees, article processing charges (APCs), or publication fees. The journal is financially supported by the Thai Society of Hematology and the National Blood Centre, Thai Red Cross Society. This financial support enables the journal to maintain its editorial operations, rigorous peer-review process, and open-access publication model without imposing fees on authors.

Advertising and Direct Marketing

The Journal of Hematology and Transfusion Medicine permits advertisements on the inside covers of the printed version of the journal. However, advertising has no influence on editorial decisions, which are made independently and solely on the basis of scientific merit.

The journal does not engage in direct marketing activities. All editorial decisions are made independently and are not influenced by advertising, commercial, or financial interests.